Vitiligo: Pathogenesis and New and Emerging Treatments

    December 2023 in “ International Journal of Molecular Sciences ”
    Javier Pérez‐Bootello, Ruth Cova‐Martín, Jorge Naharro‐Rodríguez, Gonzalo Segurado‐Miravalles
    Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

    We don't know much about this study yet.

    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 12

    1. The Efficacy of Adding Topical 5-Fluorouracil to Microneedling in the Treatment of Vitiligo: A Randomized Controlled Trial Journal of Cosmetic Dermatology · 2023
    2. Efficacy and safety comparison of basic fibroblast growth factor-related decapeptide 0.1% solution (bFGFrP) plus oral PUVA combination therapy with oral PUVA monotherapy in the treatment of vitiligo Journal of Cutaneous and Aesthetic Surgery · 2023
    3. Efficacy and safety of micro‐needling combined with topical 5‐fluorouracil and excimer light vs. excimer light alone in treatment of non‐segmental vitiligo: A comparative study Journal of Cosmetic Dermatology · 2022
    4. Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real‐world clinical practice Dermatologic Therapy · 2022
    5. Vitiligo: An Autoimmune Skin Disease and Its Immunomodulatory Therapeutic Intervention Frontiers in Cell and Developmental Biology · 2021
    6. Jak Inhibitors: Uses In Dermatology. Part 1: Overview, Applications In Vitiligo And Alopecia Areata Actas Dermo-Sifiliográficas · 2020
    7. Emerging Topical and Systemic JAK Inhibitors in Dermatology Frontiers in Immunology · 2019
    8. A Pilot Study of 2% Tofacitinib Cream with Narrowband Ultraviolet B for the Treatment of Facial Vitiligo Journal of The American Academy of Dermatology · 2019
    9. Treatment of Vitiligo with the Topical Janus Kinase Inhibitor Ruxolitinib: A 32-Week Open-Label Extension Study with Optional Narrow-Band Ultraviolet B Journal of the American Academy of Dermatology · 2018
    10. Oral Tofacitinib: A Promising Treatment in Atopic Dermatitis, Alopecia Areata, and Vitiligo Clinical and Experimental Dermatology · 2017
    11. Rapid Skin Repigmentation on Oral Ruxolitinib in a Patient with Coexistent Vitiligo and Alopecia Areata Journal of the American Academy of Dermatology · 2015
    12. Hair Follicle-Derived IL-7 and IL-15 Mediate Skin-Resident Memory T Cell Homeostasis and Lymphoma Nature medicine · 2015